FR167653, a p38 mitogen-activated protein kinase inhibitor, aggravates experimental colitis in mice

doi:10.3748/wjg.14.5851

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 38

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4963)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series.

Item

Count

PDF

363

HTML

3968

Figures (1-5)

632

Sum=4963

Oct 14, 2008 (publication date) through Nov 27, 2024

Times Cited of This Article

Times Cited (11)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Oct 14, 2008; 14(38): 5851-5856
Published online Oct 14, 2008. doi: 10.3748/wjg.14.5851

Full Size Figure Download Figure

Figure 2 Pictures of laparotomy (upper part) and resected colon (lower part). On day 14, in the FR167653-treated DSS mice stool softening and colon shortening were remarkable, as compared to the vehicle (PBS)-treated DSS mice.

Citation: Nishimura T, Andoh A, Nishida A, Shioya M, Koizumi Y, Tsujikawa T, Fujiyama Y. FR167653, a p38 mitogen-activated protein kinase inhibitor, aggravates experimental colitis in mice. World J Gastroenterol 2008; 14(38): 5851-5856
URL: https://www.wjgnet.com/1007-9327/full/v14/i38/5851.htm
DOI: https://dx.doi.org/10.3748/wjg.14.5851